APA (7th ed.) Citation

Zhang, G., Yu, D., Pan, H., Liu, J., Wang, R., Wan, Y., . . . Wang, H. (2025). Post marketing safety surveillance of atezolizumab based on a retrospective analysis of the FDA adverse events reporting system (FAERS). Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-26340-2

Chicago Style (17th ed.) Citation

Zhang, Gan, Danfeng Yu, Huan Pan, Jiong Liu, Ruling Wang, Yunyan Wan, Wuhua Zhou, and Huaxiang Wang. "Post Marketing Safety Surveillance of Atezolizumab Based on a Retrospective Analysis of the FDA Adverse Events Reporting System (FAERS)." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-26340-2.

MLA (9th ed.) Citation

Zhang, Gan, et al. "Post Marketing Safety Surveillance of Atezolizumab Based on a Retrospective Analysis of the FDA Adverse Events Reporting System (FAERS)." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-26340-2.